Therese Liechtenstein is an Investment Director at 4BIO Capital, where she leads investments in early-stage therapeutics companies. Previously, Therese worked at M Ventures, the corporate venture arm of EMD Serono. Prior to that, she managed strategic projects for the Healthcare business of EMD Serono. Therese holds a PhD in Immuno-Oncology from University College London, an MSc in Biomedical Sciences from the University of Amsterdam, and a BA in Biology and Business studies from New York University.